DA Davidson Maintains Neutral on Procter & Gamble, Raises Price Target to $160
Procter & Gamble Analyst Ratings
Buy ahead of time in 2016? Benefiting from the 'Trump trade,' assets are outpacing the market, but this time 'it's somewhat different.'
Republican presidential candidate Trump's polls are reversing, and the 'winning odds' are gradually increasing. A Merrill Lynch strategist pointed out that investors seem to be rushing to allocate to symbols that performed well after Trump's victory in 2016. What inspiration does this have for investment?
Dow, S&P 500 Settle At Record High Levels, Record 6th Consecutive Week Of Gains: Fear Index Moves To 'Extreme Greed' Zone
Tylenol, Listerine Maker Kenvue Under Activist Spotlight With Starboard Value Stake — Overhaul Ahead For The Johnson & Johnson Spinoff?
Activist Investor Starboard Takes Stake in Kenvue - WSJ
Three Events That Shook Health Insurers This Week
Over 60% of Companies That Reported Earnings This Week Beat EPS and Revenue Estimates - Earnings Scorecard
Tyra Raised to Buy by BofA Ahead of TYRA-300 Data Readout
PureCycle Gains From First-Mover Advantage And Unique Recycling Technology, Analyst Highlights Expansionary Moves
BofA Upgrades Tyra Biosciences As Investors Focus On Preclinical Data Amid High Benchmarks Set By Johnson & Johnson's Drug
Stocks Rise, Netflix Soars To Record Highs, Oil Falls Below $70, Gold Miners Rally: What's Driving Markets Friday?
Richtech Robotics Post On X, "We're Bringing Robot-run Restaurants to #Walmart Stores Across Arizona, Colorado, and Texas. Our New Signed Agreement With Ghost Kitchens Brands Will Introduce 20 New Locations."
Johnson & Johnson Unusual Options Activity
Elevance, CVS, UnitedHealth Struggle With Rising Medical Costs After COVID-19 Medicaid Policy Ends
Shares of Health Insurance Stocks Are Trading Lower Following Recent Weak Earnings and Guidance From Multiple Companies in the Sector. CVS Fell on Friday Amid a CEO Change and Weak Guidance.
UnitedHealth Group Analyst Ratings
Procter & Gamble Shares Are Trading Lower Following a Q1 Revenue Miss.
Stocks to Watch on Friday: AXP, PG and More
Procter & Gamble Sales Drop in FQ1, Forecasts Cost Headwinds in FY25